Pharmaroth Labs Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Pharmaroth Labs recent Real Value cannot be determined due to lack of data. The prevailing price of Pharmaroth Labs is $0.0. Our model determines the value of Pharmaroth Labs from analyzing the company fundamentals such as Shares Outstanding of 149.35 M, profit margin of (2.79) %, and Net Income of (91.52 K) as well as examining its technical indicators and probability of bankruptcy.
Pharmaroth Labs Total Value Analysis
Pharmaroth Labs is at this time anticipated to have valuation of 1.42 M with market capitalization of 301, debt of 250 K, and cash on hands of 33. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Pharmaroth Labs fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.42 M | 301 | 250 K | 33 |
Pharmaroth Labs Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Pharmaroth signifies not a very effective usage of assets in March.Pharmaroth Labs Profitability Analysis
The company reported the previous year's revenue of 181.56 K. Net Loss for the year was (91.52 K) with profit before overhead, payroll, taxes, and interest of 0.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Pharmaroth Stock
If you are still planning to invest in Pharmaroth Labs check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pharmaroth Labs' history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |